<DOC>
	<DOC>NCT01275794</DOC>
	<brief_summary>The purpose of the study is assessment of glycemic control and physicians satisfaction with results of DM2 OAD monotherapy</brief_summary>
	<brief_title>Screening Epidemiological Program on Compensation Evaluation of Diabetes Mellitus Type 2 (DMT2) Patients on Oral Anti-diabetic (OAD) Monotherapy and Physicians Satisfaction of Their Usage</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Patients have an established diagnosis of T2D Experience of therapy with one OAD during the from 6 months to 5 years before the registration in the Program Experience of therapy with two or more OADs and/or insulin therapy and/or incretin mimetics (exenatide) at any time before registration in the Program Absence of changes in HbAc1 level during the last year before registration in the Program</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Type 2 Diabetes</keyword>
</DOC>